Prescription Required
Xultophy is a prescription Type 2 diabetes combination insulin for blood sugar control when patients have difficulty with A1C hemoglobin test scores staying above the standard 7% threshold for acceptable blood sugar levels. This insulin pen is used for subcutaneous injection and combines two active ingredients – Degludec and Liraglutide – for effective blood sugar management. Degludec works as a long-acting insulin for up to 24 hours of blood sugar leveling and Liraglutide mimics a natural hormone in the body to control blood sugar levels, insulin levels, and digestion.
Standard dosage for Xultophy insulin is to take 1 injection per day.
Injection may be made into one of 3 acceptable injection sites: back of upper arms / thighs / abdomen (but not within a 2” radius of navel).
Switch to a different injection site for each day’s injection, never inject the same location twice with an injection. Repeated injections at the same site increases the risk of lipodystrophy.
Remove new pen from fridge approximately 1 hour before planned injection.
Preparation:
Wash your hands.
Remove the pen cap and make sure the medication is clear and has no color.
Clean the rubber seal with an alcohol swab / attach a new pen needle for each injection.
Remove the paper tab and push the needle straight onto the pen.
Remove the outer pen needle cap and keep it for removing needle following injection.
Remove the inner needle cap and discard.
Priming:
Turn the dose counter to line it up with the priming symbol shown on the dial. Then press the injection button in fully until reading ‘0’ (zero) and check to see a small amount of solution to come from the needle tip. You will need to see this before you proceed with administering the injection.
Administration:
Turn dose counter until correct prescribed dose is loaded / inject the dose.
At the injection site, insert the needle into your skin at a 90-degree angle / press the injection button down completely and hold it until ‘0’ shows in dose window / count to 6 before releasing the injection button and removing the needle / release the injection button and remove the needle from your skin.
Remove and discard needle following the proper procedure shown in your prescription.
Store the pen at room temperature after the first use.
The active ingredient in Xultophy are Insulin Degludec and Liraglutide.
Tell your doctor if you have any history of multiple endocrine neoplasia type 2, medullary thyroid carcinoma, diabetic ketoacidosis, pancreatitis, kidney or liver disease, gastroparesis (slow stomach emptying), gallstones or alcoholism before starting on Xultophy.
Medication may not be suitable for use with a mealtime insulin at the same time.
Keep insulin refrigerated at between 36°F to 46°F (2°C to 8°C) and at room temperature after first dose has been administered for each Xultophy 100 36 pen.
Be sure to change needles as indicated and do not remove outer cap on pen until you are going to give yourself an injection right after.
There is the possibility of negative drug interaction risks between Xultophy and other Rx or OTC medications, including allopurinol / amlodipine / atenolol / atorvastatin / bisoprolol / rosuvastatin/ furosemide / gabapentin / glimepiride / levothyroxine / lisinopril / losartan / pregabalin / metformin / insulin aspart / pantoprazole/ potassium chloride.
Tell your doctor of all medications you are currently taking before receiving a prescription and proceeding to buy Xultophy insulin online.
Side effects from using Xultophy are possible, and some users may experience diarrhea, headache, nausea, or common cold symptoms. If side effects are seen you may want to discontinue use and speak to your doctor again about insulin pen alternatives to Xultophy as part of Type 2 diabetes treatment.
